Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.33
-0.2000-1.14%
Post-market: 17.330.00000.00%16:04 EDT
Volume:1.28M
Turnover:22.14M
Market Cap:35.63B
PE:9.11
High:17.37
Open:17.30
Low:17.06
Close:17.53
52wk High:18.19
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.94
T/O Rate:0.54%
Dividend:0.99
Dividend Rate:5.72%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.74
PE(LYR):14.88

Loading ...

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

GlobeNewswire
·
Mar 31

China Securities: Profitability in VC and EC Segments Expected to Improve, Focus on High-Beta Stocks

Stock News
·
Mar 30

588-unit Pinery Residences sells 92.5% of units at over $2,500 psf average on launch day

Gerine Tang Yi Qian
·
Mar 28

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

GlobeNewswire
·
Mar 26

Shrinking EUA supply puts EU ETS under policy strain

Fastmarkets
·
Mar 26

Ecopetrol Says No Violations, Contract Breaches to Date Related to Formal Charges Against President Ricardo Roa

MT Newswires Live
·
Mar 26

Ecopetrol says ‘committed’ to safeguarding interests of company, shareholders

TIPRANKS
·
Mar 25

EC urged to stop Fifa’s ‘aggressive and exploitative’ World Cup ticket prices

cityam
·
Mar 24

Ecopetrol price target raised to $13 from $8.70 at Goldman Sachs

TIPRANKS
·
Mar 23

Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

Dow Jones
·
Mar 20

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
Mar 20

Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 19

S’pore private residential market to remain resilient despite Mideast tensions: HSBC

Jovi Ho
·
Mar 19

Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Dow Jones
·
Mar 18

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Mar 18

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Mar 17

Sector Update: Energy Stocks Higher in Afternoon Trading

MT Newswires Live
·
Mar 13

Ecopetrol President Ricardo Roa Indicted for Alleged Influence Peddling

MT Newswires Live
·
Mar 12

Auto a key market to drive steel decarbonization: SteelWatch

Fastmarkets
·
Mar 12

Press Release: Ecopetrol's 2025 Earnings Distribution Proposal

Dow Jones
·
Mar 05